risperidone has been researched along with Drooling in 7 studies
Risperidone: A selective blocker of DOPAMINE D2 RECEPTORS and SEROTONIN 5-HT2 RECEPTORS that acts as an atypical antipsychotic agent. It has been shown to improve both positive and negative symptoms in the treatment of SCHIZOPHRENIA.
risperidone : A member of the class of pyridopyrimidines that is 2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one carrying an additional 2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl group at position 2.
Excerpt | Relevance | Reference |
---|---|---|
"Preschool children tolerated low-dose risperidone well with no serious adverse effects observed over a 6-month treatment period." | 2.72 | Risperidone in preschool children with autistic spectrum disorders: an investigation of safety and efficacy. ( Belden, A; Heffelfinger, A; Luby, J; Mrakotsky, C; Spitznagel, E; Stalets, MM; Williams, M, 2006) |
" Mean CLZ dosage during the combined treatment was 474." | 2.43 | Risperidone augmentation of clozapine: a critical review. ( Christodoulou, GN; Ferentinos, PP; Havaki-Kontaxaki, BJ; Kontaxakis, VP; Paplos, KG; Pappa, DA, 2006) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 5 (71.43) | 29.6817 |
2010's | 2 (28.57) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Liang, CS | 1 |
Liao, WC | 1 |
Yang, FW | 1 |
Ho, PS | 1 |
Usta, MG | 1 |
Tufan, AE | 1 |
Cüceloğlu, EA | 1 |
Freudenreich, O | 1 |
Goff, DC | 1 |
Kontaxakis, VP | 1 |
Ferentinos, PP | 1 |
Havaki-Kontaxaki, BJ | 1 |
Paplos, KG | 1 |
Pappa, DA | 1 |
Christodoulou, GN | 1 |
Luby, J | 1 |
Mrakotsky, C | 1 |
Stalets, MM | 1 |
Belden, A | 1 |
Heffelfinger, A | 1 |
Williams, M | 1 |
Spitznagel, E | 1 |
Panagiotidis, PT | 1 |
Fountoulakis, KN | 1 |
Siamouli, M | 1 |
Magiria, S | 1 |
Iacovides, A | 1 |
Kaprinis, G | 1 |
2 reviews available for risperidone and Drooling
Article | Year |
---|---|
Antipsychotic combination therapy in schizophrenia. A review of efficacy and risks of current combinations.
Topics: Antipsychotic Agents; Clinical Trials as Topic; Clozapine; Delirium; Drug Therapy, Combination; Evid | 2002 |
Risperidone augmentation of clozapine: a critical review.
Topics: Antipsychotic Agents; Clozapine; Drug Interactions; Drug Resistance; Drug Therapy, Combination; Dysk | 2006 |
1 trial available for risperidone and Drooling
Article | Year |
---|---|
Risperidone in preschool children with autistic spectrum disorders: an investigation of safety and efficacy.
Topics: Antipsychotic Agents; Anxiety; Autistic Disorder; Behavior Therapy; Child Behavior Disorders; Child, | 2006 |
4 other studies available for risperidone and Drooling
Article | Year |
---|---|
Drug-induced sialorrhoea and excessive saliva accumulation.
Topics: Antipsychotic Agents; Benzodiazepines; Cholinesterase Inhibitors; Clozapine; Deglutition Disorders; | 2009 |
Risperidone-induced sialorrhea: dose-related?
Topics: Dose-Response Relationship, Drug; Female; Humans; Middle Aged; Risperidone; Schizophrenia; Sialorrhe | 2010 |
Diphenhydramine use in the treatment of risperidone-induced sialorrhea.
Topics: Adolescent; Antipsychotic Agents; Diphenhydramine; Dose-Response Relationship, Drug; Follow-Up Studi | 2012 |
Risperidone-induced sialorrhea responsive to biperiden treatment.
Topics: Administration, Oral; Adolescent; Antipsychotic Agents; Biperiden; Dose-Response Relationship, Drug; | 2007 |